David Goodman's lobbying: the registrations they file and every meeting they've reported since November 2021.
← Lobbying
Registrant (responsible officer)
David Goodman
Chief Executive Officer
For companies and organizations, the most senior paid officer files the registration and the monthly reports, whoever attended the meeting.
Meetings this Parliament
175
Since Nov 2021
205
Active registrations
1
Dec 2024 Reports per month Nov 2026
Reported meetings
Jean-Francois Courtois · Directeur exécutif, Innovation, Science and Economic Development Canada (ISED)
Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Alison McConnell · Directrice adjointe, Innovation, Science and Economic Development Canada (ISED)
Inga Pusca · Gestionnaire princ. d'investissements p. int., Innovation, Science and Economic Development Canada (ISED)
and 1 more Show fewer
Nadeen Abd El Aal · Analyste princ. de politiques, Innovation, Science and Economic Development Canada (ISED)
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Official report
Jean-Francois Courtois · Directeur exécutif, Innovation, Science and Economic Development Canada (ISED)
Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Alison McConnell · Directrice adjointe, Innovation, Science and Economic Development Canada (ISED)
Inga Pusca · Gestionnaire princ. d'investissements p. int., Innovation, Science and Economic Development Canada (ISED)
and 1 more Show fewer
nadeen Abd El Aal · Analyste princ. de politiques, Innovation, Science and Economic Development Canada (ISED)
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Official report
Mackenzy Metcalfe · Conseillère en politiques, Finance Canada (FIN)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Mackenzy Metcalfe · Conseillère en politiques, Finance Canada (FIN)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Official report
Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Official report
Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Official report
Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Read more
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Sandenga Yeba · Deputy chief of staff and policy director, Health Canada (HC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Sandenga Yeba · Deputy chief of staff and policy director, Health Canada (HC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Sandenga Yeba · Deputy chief of staff and policy director, Health Canada (HC)
Policies aimed at facilitating generic drug repurposing.
Official report
Manuela Tomic · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Sandenga Yeba · Deputy chief of staff and policy director, Health Canada (HC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Manuela Tomic · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Paul Moen · Chief of Staff, Innovation, Science and Economic Development Canada (ISED)
Cédrick Devedeux Delorme · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Sandenga Yeba · Deputy chief of staff and policy director, Health Canada (HC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Sandenga Yeba · Deputy chief of staff and policy director, Health Canada (HC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Manuela Tomic · Conseillère politique, Innovation, Science and Economic Development Canada (ISED)
Cédrick Devedeux Delorme · Directeur adjoint des Opérations, Innovation, Science and Economic Development Canada (ISED)
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Official report
Élyse Moisan · Conseiller politique, Finance Canada (FIN)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Official report
Sandenga Yeba · Deputy chief of staff and policy director, Health Canada (HC)
Discussion regarding the launch of new branded product in the rare disease space
Official report
Mackenzy Metcalfe · Conseillère en politiques, Finance Canada (FIN)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Manuela Tomic · Conseillère politique, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Kerry Robinson · Director General, Health Canada (HC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Rodrigo Arancibia · Directeur général, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Cédrick Devedeux Delorme · Conseiller Principal, Innovation, Science and Economic Development Canada (ISED)
David McFarlane · Directeur adjoint, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
← Newer
Page 7
Older →
From the Office of the Commissioner of Lobbying's open data , published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence .
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.